This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Neoplasms  • Alert me on articles by topic

Hubert T. Greenway Jr, MD; Joy M. Twersky, MD; Shanna B. Meads, MD; Benjamin F. Kelley

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Melanoma is the most common malignancy of the foot¹ and is more likely to be misdiagnosed on the foot than in any other location.² Clinical mimics include verruca, onychomycosis, subungual hematoma, or ischemic digits.^2-3

Report of Cases

Recently at our institution, we treated 8 melanomas of the foot or ankle over a 6-month period. After obtaining institutional review board approval, we gathered the clinical data of patients with melanoma presenting to our clinic between July 1, 2003, and December 31, 2003, from our cutaneous surgery unit database at Scripps Clinic, La Jolla, Calif. Of the 69 melanomas treated in our unit during this 6-month interval, 8 melanomas (12%) were located on the foot and ankle, in contrast to our 21-year incidence of 4% (January 1985–December 2005, unpublished data). Clinical and pathologic characteristics of these 8 patients were . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION

RELATED ARTICLES

Store-and-Forward Teledermatology in Skin Cancer Triage: Experience and Evaluation of 2009 Teleconsultations
David Moreno-Ramirez, Lara Ferrandiz, Adoracion Nieto-Garcia, Rafael Carrasco, Pedro Moreno-Alvarez, Rafael Galdeano, Esther Bidegain, Juan J. Rios-Martin, and Francisco M. Camacho
Arch Dermatol. 2007;143(4):479-483.
ABSTRACT | FULL TEXT  

Melanoma Outcomes for Medicare Patients: Association of Stage and Survival With Detection by a Dermatologist vs a Nondermatologist
Michelle L. Pennie, Seaver L. Soon, Jessica B. Risser, Emir Veledar, Steven D. Culler, and Suephy C. Chen
Arch Dermatol. 2007;143(4):488-494.
ABSTRACT | FULL TEXT  

Multiple Melanomas After Treatment for Hodgkin Lymphoma in a Non-Dutch p16-Leiden Mutation Carrier With 2 MC1R High-Risk Variants
Adina Figl, Ranjit K. Thirumaran, Selma Ugurel, Andreas Gast, Kari Hemminki, Rajiv Kumar, and Dirk Schadendorf
Arch Dermatol. 2007;143(4):495-499.
ABSTRACT | FULL TEXT  

Phenotypic Variation in Familial Melanoma: Consequences for Predictive DNA Testing
Wilma Bergman and Nelleke A. Gruis
Arch Dermatol. 2007;143(4):525-526.
EXTRACT | FULL TEXT